BPC-157: What It Is, What the Research Says, and What You Need to Know

A gut-derived peptide showing remarkable healing properties in preclinical research

Last updated: May 1, 2026

BPC-157 stands for Body Protection Compound-157 — a sequence of 15 amino acids originally isolated from human gastric juice.

It is a synthetic analog of a naturally occurring protein fragment in the stomach lining. Despite its origin, researchers have studied its effects far beyond the gut — including tendons, ligaments, muscles, and the nervous system.

It is strictly classified as a research peptide and has not been approved by the FDA for human therapeutic use.

• Animal studies show accelerated healing of tendon, ligament, and muscle injuries compared to controls.
• Research in rats demonstrates significant reduction in inflammation and improved recovery from surgical cuts and tears.
• Preclinical models suggest neuroprotective effects, with some studies showing improved recovery after traumatic brain injury.
• Studies in rodents indicate it may protect against NSAID-induced gut damage and promote gut healing.
• No completed double-blind human clinical trials exist as of 2026 — all human evidence is anecdotal.

These reflect how researchers and research communities discuss this compound — not therapeutic recommendations.

• Research into accelerated tendon and ligament repair
• Gut healing and intestinal permeability studies
• Post-surgical recovery in preclinical models
• Neurological injury research

Upregulates growth hormone receptors, promotes angiogenesis (new blood vessel formation), and modulates nitric oxide synthesis to accelerate tissue repair.